Non-Invasive Method and System of Signaling a Hyper or Hypoglycemic State

• US 20090163825A1
• Filed: 12/19/2007
• Published: 06/25/2009
• Est. Priority Date: 12/19/2007
• Status: Abandoned Application

• Current Assignee: Cooper Health System
• Original Assignee: Cooper Health System
• Inventors: Hirsh, Robert, Torjman, Marc C.
• Application Number:
  US11/960,186
• Publication Number:
  US 20090163825A1
• Time in Patent Office: Days
• US Class Current: 600/532
• CPC Class Codes: A61B 5/082 Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath A61B5/083, A61B5/091 take precedence

Abstract

A method and system for determining a hyper or hypoglycemic state in a diabetic patient using acetone concentration in exhaled breath by means of a nasal device containing an acetone sensor. When a hyper or hypoglycemic state is detected, an alarm is issued. The alarm can be audible and/or can be sent wirelessly to a local or remote computer system.

Claims

1. A system for signaling a dysglycemic state comprising

means to continually or periodically measure acetone concentration in exhaled breath comprising sensor means and means to maintain the sensor means in a nasal passage,

means to process acetone concentration data and calculate changes in the acetone concentration in the exhaled breath,

means to determine presence of a dysglycemic state based on the calculated changes in acetone concentration, and

means to issue an alarm when the presence of a dysglycemic state is determined.

2. The system of claim 1 wherein the means to continually or periodically measure acetone concentration comprises a nasal projection, a cannula tube, a vacuum source, a controller, an acetone analyzer, and an alarm, the system adapted to establish a continual or periodic negative pressure at the nasal projection, to conduct exhaled breath to the acetone analyzer, and to continually or periodically analyze acetone concentration in the exhaled breath.

3. The system of claim 1 wherein the alarm means is an audible or visual signal.

4. The system of claim 1 wherein the means to continually or periodically measure acetone concentration comprises a mouth projection adapted to receive exhaled breath.

5. The system of claim 1 including means to measure temperature of the exhaled breath and means to compare the measured temperature to an expected temperature and thereby determine if the system is receiving exhaled breath.

6. The system of claim 1 including means to measure temperature of the exhaled breath, means to compare the measured temperature to an expected temperature and thereby determine if the system is receiving exhaled breath, and means to issue an audible or visual disconnect alarm if the measured temperature does not vary physiologically with respect to time.

7. The system of claim 1 including means to determine periodicity of acetone concentration with respect to a respiratory cycle.

8. The system of claim 1 including means to measure acetone concentration in end-tidal alveolar gas, means to calculate if the measured acetone concentration in the end-tidal alveolar gas exceeds a predetermined threshold, and means to signal a dysglycemic state if the calculated acetone concentration exceeds the predetermined threshold.

9. The system of claim [8] further including means to determine the degree to which the calculated acetone concentration exceeds the predetermined threshold and means to signal the degree of dysglycemic state based on the degree to which the acetone concentration exceeds the predetermined threshold.

10. The system of claim 1 wherein the means to measure acetone concentration comprises a thermistor adapted to measure temperature within the cannula, the system comprising means to compare the measured temperature to an expected temperature and thereby determine if the cannula is physiologically connected to the patient.

11. The system of claim 2 comprising means to determine changes in acetone concentration as a function of respiration and to compare changes in acetone concentration to expected changes in acetone concentration due to respiration.

12. The system of claim 2 further including means to measure CO₂ concentration in the exhaled breath, means to compare the measured concentration to expected concentration, and means to signal an error if the measured concentration varies from the expected concentration by a predetermined value.

13. A process comprising (A) continuously or periodically determining acetone concentration in exhaled breath of a diabetic patient, (B) determining presence of a dysglycemic state of the patient by calculating changes in the acetone concentration, and (C) issuing an alarm when the dysglycemic state is determined.

14. The process of claim [13] comprising determining changes in acetone concentration as a function of respiration and to compare changes in acetone concentration to expected changes in acetone concentration due to respiration.

15. The process of claim [13] comprising measuring CO₂ concentration in the exhaled breath, comparing the measured concentration to expected concentration, and signaling an error if the measured concentration varies from the expected concentration by a predetermined value.

16. The process of claim [13] comprising measuring temperature in exhaled breath and comparing measured temperature to an expected temperature and thereby determine if expired breath is being received.

17. The process of claim [13] comprising measuring temperature, comparing the measured temperature to an expected temperature, and thereby determining if exhaled breath is being received, and further comprising signaling an error or disconnect if the measured temperature does not vary physiologically with respect to time.